You are here

  • Overview
  • Keynote Speakers
  • Agenda
  • Sponsors
  • Location
  • 8:30 AM to 5:00 PM
  • Vantage Venue, 150 King Street W
    27th floor

We are pleased to invite you to the 4th Annual Lung Oncology Research Day. This annual event celebrates our achievements in clinical and translational research. The purpose of this conference is for the lung group to share, update, and discuss ongoing lung cancer research across the entire multi-disciplinary spectrum with participation from researchers, clinicians, and trainees. 

This year, Research Day will be held on Friday, November 03, 2023 at the Vantage Venues, 27th floor located at 150 King Street West in downtown Toronto.

Trainees (i.e., clinical fellows, postdoctoral fellows,& residents) currently working under the supervision of a Principal Investigator at the lung site are invited to submit an abstract for an oral presentation or a poster.

Abstracts submitted to international or national meetings over the past year are welcome. There will be Awards for the best clinical and basic science presentations.

Registration is free and we encourage everyone to register as soon as possible.  

If you plan to submit an abstract, please register and then email your abstract to Fatemeh Zaeimi, 

Please mark your calendars for November 03, 2023 and we look forward to seeing you there!

Abstract Submission Deadline:  Tuesday, October 10, 2023 at 4:00 p.m. (no late submissions will be accepted)
Registration Closes:  Friday, October 20, 2023 at 4:00 pm.

Online registration is mandatory for all presenters and general attendees.


Kurt A. Schalper, M.D., Ph.D.

Dr. Schalper is an associate professor in the Department of Pathology and Medicine at Yale School of Medicine and leads the Translational Immuno-Oncology Laboratory (T.I.L.) in the Yale Cancer Center. Dr. Schalper’s research is focused on understanding the immunobiology of human solid tumors and developing molecular biomarkers for prediction of response or resistance to therapies. 

Colin Collins, Ph.D.

Dr. Collins is a tenured professor at the University of British Columbia. Dr. Collins specializes in translational cancer genomics and the applications of integrative analysis of multi-omics data to discovery and functional studies. Based at the Vancouver Prostate Centre, where he leads the Laboratory for Advanced Genome Analysis, Dr. Collins’ lab focuses on translational cancer genomics to study mechanisms of treatment resistance for the benefit of precision oncology.

Rayjean J. Hung, Ph.D., M.S.

Dr. Rayjean Hung holds the Tier 1 Canada Research Chair in Integrative Molecular Epidemiology. She is the head of the Prosserman Centre for Population Health Research, associate director of Population Health at the Lunenfeld-Tanenbaum Research Institute and professor of Epidemiology at the University of Toronto. Dr. Hung’s research focuses on identifying individual molecular profiles related to cancer risk and progression.



4th Annual Toronto Lung Oncology Research Day Agenda, Friday November 3, 2023

8:30 AM-9:00 AM
Registration and Breakfast
9:00 AM-9:10 AM
Welcome and Opening Remarks
Dr. Marc de Perrot
9:05 AM–10:10 AM
Session I – Personalized Therapy, Better Staging & More Precise Immunotherapy Treatment for NSCLC
Session Chair: Dr. Marc de Perrot

Dr. Ming Tsao
Title: Invasion in lung adenocarcinoma - can the pathologists can it right?

Dr. Phedias Diamandis
Title: AI in pathology and its application

Dr. Roger Hsu
Title: Molecular Alterations in Non-Small cell Lung Cancer arising in Emphysematous and Fibrotic Lungs

Joshua Rosen
Title: KRASG12C inhibitors in patient-derived NSCLC models

15’ Q & A Panel Discussion

Coffee Break
10:25 AM-11:40 AM
Session I – cont. Session Chair : Dr. Adrian Sacher

Dr. Benjamin Lok
Title: PARP inhibitor radiosensitization enhances anti-PD-L1 immunotherapy through derepression of chemokine translation in small cell lung cancer

Dr. Andrew Hope
Title: AI detection of ILD in lung cancer patients undergoing radiation therapy

Dr. Mercedes Herrera
Title: Molecular characterization of Pleural Mesothelioma subgroups with Digital Space Profiling and correlation with clinical and histological aracteristics

Dr. Yuchen Li
Title: Single organ metastatic sites in NSCLC: patient characteristics, treatment patterns and outcomes from a large retrospective Canadian database

Dr. Daniel Tong
Title: Ablative techniques for lung metastases: baseline characteristics and outcomes of patients treated with stereotactic radiotherapy versus radiofrequency ablation

15’ Q & A Panel Discussion  

Keynote Speaker I: Dr. Kurt Schalper, Director, Translational Immuno-oncology Laboratory, Yale Cancer Center
Topic: Decoding the role of the tumor microenvironment in immune evasion and therapeutic sensitivity of lung cancer
1:30 PM-2:50 PM
Session II – Updates on Clinical Trials and New Treatments
Session Chair : Dr. Benjamin Lok

Keynote Speaker
Dr. Rayjean Hung, Canada Research Chair in Integrative Molecular Epidemiology, Head, Prosserman Centre for Population Health Research, Associate Director of Population Health, Lunenfeld-Tanenbaum Research Institute, Sinai Health , Professor of Epidemiology, Dalla Lana School of Public Health, University of Toronto
Title: Circulating Proteome and Lung Cancer Early Detection

Dr. Frances Sheppard
Title: Pre-op versus Post- op Therapy in Surgically Resectable NSCLC

Dr. Janet Papadakos
Title: Lung educational needs assessment

Dr. Patrick Rogalla
Title: To learn outweighs designing: Deep learning image reconstruction in CT

15’ Q & A Panel Discussion

2:50 PM-3:05 PM
Coffee Break
3:05 PM-3:30 PM
Session II – Cont.
Session Chair : Dr. Marc de Perrot

Keynote Speaker II: Dr. Colin Collins, Professor, Senior Scientist and Director of laboratory for advanced genome analysis at University of British Columbia in Vancouver, BC
Topic: Translational Prostate Cancer Research. What Can It Teach Us?

3:30 PM-4:10 PM
Dr. Jillian Tsai
Title: Consolidation use of radiotherapy to block oligoprogression

Dr. Hannah Bacon
Title: Association of Artificial Intelligence-Screened Interstitial Lung Disease with Radiation Pneumonitis and Mortality in Locally Advanced Non-Small Cell Lung Cancer

Dr. Jamie Feng
Title: Effect of TP53 co-mutation in non-small cell lung cancer (NSCLC) with driver mutations

15’ Q & A Panel Discussion

4:10 PM-5:00 PM
Awards Ceremony and Recognition

Gold Sponsors



Silver Sponsors


Friday, November 3, 2023 - 08:30 to 17:00